Page 8 - Drug Makers In India

Drug controller cracks whip on e-pharmacies selling drugs without licences

Last December the Delhi High Court had said online sale of medicines without a licence was injuncted, and had instructed the government to ensure that the same was prohibited forthwith

Indian pharmaceutical companies spread business to avoid regulatory ire

Increased USFDA import alerts could be reason for finding alternative sites

The antibiotics challenge

Don't extend price caps on drugs

Domestic drug portfolio a key driver of Ajanta Pharma's growth prospects

Industry beating growth along with high US sales are keeping analysts positive on the company's earnings prospects

Drug marketers to be held liable for quality churned out by third parties

Onus of quality and labelling is currently with drug maker, marketers just need licence to sell. Rule change will make marketers more accountable, greater scrutiny may boost quality, say experts